Steven D. Ertel

2014

In 2014, Steven D. Ertel earned a total compensation of $454.8K as Executive Vice President and Chief Operating Officer at Acceleron Pharma, a 50% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$117,250
Salary$335,000
Other$2,500
Total$454,750

Ertel received $335K in salary, accounting for 74% of the total pay in 2014.

Ertel also received $117.3K in non-equity incentive plan and $2.5K in other compensation.

Rankings

In 2014, Steven D. Ertel's compensation ranked 10,588th out of 13,032 executives tracked by ExecPay. In other words, Ertel earned more than 18.8% of executives.

ClassificationRankingPercentile
All
10,588
out of 13,032
19th
Division
Manufacturing
4,032
out of 4,966
19th
Major group
Chemicals And Allied Products
1,386
out of 1,686
18th
Industry group
Drugs
1,110
out of 1,365
19th
Industry
Biological Products, Except Diagnostic Substances
199
out of 236
16th
Source: SEC filing on April 15, 2016.

Ertel's colleagues

We found four more compensation records of executives who worked with Steven D. Ertel at Acceleron Pharma in 2014.

2014

John Knopf

Acceleron Pharma

Chief Executive Officer

2014

John Quisel

Acceleron Pharma

General Counsel

2014

Matthew Sherman

Acceleron Pharma

Chief Medical Officer

2014

Kevin McLaughlin

Acceleron Pharma

Chief Financial Officer

You may also like